Correlation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 11, 2014, Pages 4282-4290

  Che, Yi Qun ^a   Feng, Lin ^a   Rong, Wei Qi ^a   Shen, Di ^a   Wang, Qian ^a   Yang, Lin ^a   Qi, Jun ^a   Huang, Chang Zhi ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Immunoglobulin; Prognosis; Subgroups

Indexed keywords

ALPHA FETOPROTEIN; CD19 ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CD19+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RECURRENCE RISK; T LYMPHOCYTE SUBPOPULATION;

EID: 84918572532     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fatourou EM, Koskinas JS. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Rev Anticancer Ther 2009; 9: 1499-1510.
2. Schieving JH, de Vries M, van Vugt JM, Weemaes C, van Deuren M, Nicolai J, Wevers RA, Willemsen MA. Alpha-fetoprotein, a fascinating protein and biomarker in neurology. Eur J Paediatr Neurol 2014; 18: 243-248.
3. Korangy F, Höchst B, Manns MP, Greten TF. Immune responses in hepatocellular carcinoma. Dig Dis 2010; 28: 150-154.
4. Behboudi S, Pereira SP. Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma. World J Hepatol 2010; 2: 256-260.
5. Benkhoucha M, Molnarfi N, Schneiter G, Walker PR, Lalive PH. The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity. J Neuroinflammation 2013; 10: 154.
6. Hayashida M, Kawano H, Nakano T, Shiraki K, Suzuki A. Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells. Proc Soc Exp Biol Med 2000; 225: 143-150.
7. Volarevic V, Misirkic M, Vucicevic L, Paunovic V, Simovic Markovic B, Stojanovic M, Milovanovic M, Jakovljevic V, Micic D, Arsenijevic N, Trajkovic V, Lukic ML. Metformin aggravates immune-mediated liver injury in mice. Arch Toxicol 2014; [Epub ahead of print].
8. Finn RS. Emerging targeted strategies in advanced hepatocellular carcinoma. Semin Liver Dis 2013; 33 Suppl 1: S11-S19.
9. Bassi N, Caratozzolo E, Bonariol L, Ruffolo C, Bridda A, Padoan L, Antoniutti M, Massani M. Management of ruptured hepatocellular carcinoma: implications for therapy. World J Gastroenterol 2010; 16: 1221-1225.
10. Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery 2012; 151: 213-222.
11. Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS. Intratumoral regulatory T cells alone or in combination withcytotoxic T cells predict prognosis of hepatocellular carcinomaafter resection. Med Oncol 2012; 29: 1817-1826.
12. Ma WJ, Wang HY, Teng LS. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J Surg Oncol 2013; 11: 212.
13. Schuch A, Hoh A, Thimme R. The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection. Front Immunol 2014; 5: 258.
14. Sha WH, Zeng XH, Min L. The correlation between NK cell and liver function in patients with primary hepatocellular carcinoma. Gut Liver 2014; 8: 298-305.
15. Shabani Z, Bagheri M, Zare-Bidaki M, Hassanshahi G, Arababadi MK, Mohammadi Nejad M, Kennedy D. NK cells in hepatitis B virus infection: a potent target for immu-notherapy. Arch Virol 2014; 159: 1555-1565.
16. Fatourou EM, Koskinas JS. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Rev Anticancer Ther 2009; 10: 1499-510.
17. Gopal P, Yopp AC, Waljee AK, Chiang J, Nehra M, Kandunoori P, Singal AG. Factors that affect accuracy of a-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12: 870-877.